Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Alzheimer's
Alzheimer's
Page 5 of 8
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By
Sy Mukherjee
June 9, 2021
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By
Sy Mukherjee
June 7, 2021
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By
Sy Mukherjee
May 25, 2021
Newsletters
A week about Alzheimer’s drug development
By
Sy Mukherjee
March 18, 2021
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By
Sy Mukherjee
February 28, 2020
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By
Sy Mukherjee
December 5, 2019
Newsletters
Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By
Sy Mukherjee
December 2, 2019
Newsletters
Bill Gates Commits $10 Million More for Alzheimer’s Research to ‘Part the Cloud’
By
Sy Mukherjee
November 5, 2019
Newsletters
Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By
Sy Mukherjee
October 23, 2019
Health
Roche Reports Another Failure in Big Pharma’s Search for Alzheimer’s Treatment
By
Lucas Laursen
January 30, 2019
Health
A New Blood Test Could Detect Alzheimers 10 Years Earlier
By
Emily Price
January 21, 2019
Magazine
The Power of a Joint Venture
By
Clifton Leaf
January 18, 2019
Could This Radical New Approach to Alzheimer’s Lead to a Breakthrough?
By
Rick Tetzeli
January 18, 2019
Magazine
Alzheimer’s: A Trail of Disappointment for Big Pharma
By
Sy Mukherjee
January 18, 2019
Health
Is an Alzheimer’s Vaccine Possible? This Woman Thinks So
By
Sy Mukherjee
October 3, 2018
Most Popular
Personal Finance
Peter Thiel makes his biggest donation in years to help defeat California’s billionaire wealth tax
By
Nick Lichtenberg
Europe
Americans have been quietly plundering Greenland for over 100 years, since a Navy officer chipped fragments off the...
By
Paul Bierman
and
The Conversation
Health
The head of marketing at Slate posted on LinkedIn requesting cleaning services as a benefit at her company. The next...
By
Sydney Lake